XML 31 R22.htm IDEA: XBRL DOCUMENT v3.22.1
EQUITY COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2021
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF EQUITY COMPENSATION

 

   Three Months Ended 
   March 31, 
   2021   2020 
Compensation cost recognized:          
Selling, general & administrative  $4,271,792   $79,289 
Research & development   273,223    6,753 
   $4,545,015   $86,042 
SCHEDULE OF STOCK OPTION ACTIVITY

Stock option activity under the 2015 Stock Option Plan (the “Plan”) during the period indicated below were as follows:

 

   Number of Shares Subject to Issuance   Weighted-average Exercise Price   Weighted-average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding at December 31, 2020   637,882   $2.50    2.55 years   $5,686,421 
Granted   221,843    10.38           
Exercised   (332,301)   2.37           
Outstanding at March 31, 2021   527,424   $5.89    3.58 years   $1,768,591 
                     
Exercisable at March 31, 2021   160,860   $         2.59    2.27 years   $932,022 
SCHEDULE OF RESTRICTED STOCK UNITS OUTSTANDING

 

   Number of
Shares
   Weighted
Average
Grant Date
Fair Value
   Aggregate
Intrinsic
Value
 
             
Outstanding at December 31, 2020   1,754   $11.40   $- 
Granted   405,576    10.62      
Vested and settled in shares   (1,754)   11.40      
                
Outstanding at March 31, 2021   405,576   $10.62   $11,568 
SCHEDULE OF PERFORMANCE STOCK UNITS OUTSTANDING

 

   Number of
Shares
   Weighted
Average
Grant Date
Fair Value
   Aggregate
Intrinsic
Value
 
             
Outstanding at December 31, 2020   265,942   $7.91   $- 
Granted and Vested   -    -      
                
Outstanding at March 31, 2021   265,942   $7.91   $         -